HCV, HBV, HIV Testing During Consultation With Anesthesiologist
NCT04286347 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 363
Last updated 2021-12-02
Summary
The aim of the study is to assess the feasibility of HCV, HBV, HIV testing (according to the national guidelines) during consultation with Anesthesiologist before a planned surgery in Lariboisiere Hospital, Paris, France. The feasibility will be the number of tested patients divided by the number of patients who should have been tested according to the national guidelines (for each virus).
Conditions
- HCV
- HBV
- Hiv
Interventions
- PROCEDURE
-
HCV, HBV, HIV tests
HCV, HBV, HIV testing during consultation with Anesthesiologist before a planned surgery
Sponsors & Collaborators
- collaborator INDUSTRY
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-05
- Primary Completion
- 2021-10-27
- Completion
- 2021-10-27
Countries
- France
Study Locations
More Related Trials
-
Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load
NCT00454337 ·Status: COMPLETED ·Phase: PHASE3
-
Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)
NCT02247687 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of Innovative Combinatorial stratégies of Anti-latency and Anti-immune Activation Drugs Targeting HIV Reservoir
NCT04741100 ·Status: WITHDRAWN
-
Study of Entry and Continuation in Care for People Living With HIV in French Guiana
NCT05354934 ·Status: UNKNOWN
-
Research In Viral Eradication of HIV Reservoirs
NCT02336074 ·Status: COMPLETED ·Phase: PHASE2
-
Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France
NCT06799338 ·Status: RECRUITING
-
Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects
NCT00529243 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance
NCT00120783 ·Status: TERMINATED ·Phase: PHASE2
-
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
NCT00855413 ·Status: TERMINATED ·Phase: PHASE4
-
HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
NCT04513626 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
NCT00005012 ·Status: COMPLETED ·Phase: PHASE2
-
A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure
NCT01641367 ·Status: COMPLETED ·Phase: PHASE4
-
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
NCT01029249 ·Status: COMPLETED
-
Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV
NCT05215704 ·Status: RECRUITING
-
Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based Therapy
NCT05303337 ·Status: RECRUITING
-
Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)
NCT04581746 ·Status: UNKNOWN ·Phase: NA
-
Latent HIV-1, Viral Suppress and Hope for HIV Cure
NCT04938518 ·Status: UNKNOWN
-
VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption
NCT02471326 ·Status: COMPLETED ·Phase: PHASE1
-
Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study
NCT01038401 ·Status: COMPLETED ·Phase: NA
-
CSP #512 - Options in Management With Anti-Retrovirals
NCT00050089 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients
NCT00504452 ·Status: TERMINATED ·Phase: PHASE2
-
Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination Cabotegravir+Rilpivirina.
NCT06643897 ·Status: COMPLETED ·Phase: NA
-
Assessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 Genotype
NCT05482854 ·Status: UNKNOWN ·Phase: NA
-
Analytic Treatment Interruption (ATI) to Assess HIV Cure
NCT02437526 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Analytical Treatment Interruption in HIV Positive Patients
NCT02590354 ·Status: COMPLETED ·Phase: NA